Shareholder Investigation of Teladoc Health, Inc.

Teladoc Health, Inc. (TDOC) CFO Accused of Engaging in Inappropriate Relationships and Insider Trading

According to the complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 3, 2016 and December 5, 2018, Mark Hirschorn, Executive Vice President, Chief Operating Officer, and Chief Financial Officer of Teladoc Health, Inc. (TDOC) Health engaged in an inappropriate sexual relationship with a subordinate many levels below him, engaged in insider trading with the subordinate, and caused the subordinate to receive a series of unqualified promotions. On December 5, 2018, the truth came out when the Southern Investigative Research Foundation published an article reporting the inappropriate conduct. Following the publication, Teladoc’s stock price fell sharply by $4.00, or 6.79%, to close at $55.81.

Teladoc Health, Inc. (TDOC) Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can please send us a message via the Shareholder Information form below.

Send us a message for more information.

Skip to content